Vanguard Capital Management’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
Other funds holding BOLT
LCM
NCNMGF
Vanguard Capital Management's BOLT Position: Q3 2026 in Review
Vanguard Capital Management held its Bolt Biotherapeutics (BOLT) position steady in Q3 2026 at 7,060 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #3960.
Vanguard Capital Management first reported a position in BOLT in Q1 2026 and has held it in 3 quarters since. The position peaked at $28.5K in Q1 2026. 23 funds tracked by Wall St. Rank hold BOLT as of Q3 2026.
- Vanguard Capital Management held 7,060 shares of Bolt Biotherapeutics worth $26K as of Q3 2026.
- Vanguard Capital Management left its Bolt Biotherapeutics share count unchanged in Q3 2026.
- Bolt Biotherapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3960 holding.
- Vanguard Capital Management first reported a position in Bolt Biotherapeutics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Bolt Biotherapeutics position peaked at $28.5K in Q1 2026.
- 23 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.